Related references
Note: Only part of the references are listed.Endothelial cadherins in cancer
Georg Breier et al.
CELL AND TISSUE RESEARCH (2014)
The sweet and sour of serological glycoprotein tumor biomarker quantification
Uros Kuzmanov et al.
BMC MEDICINE (2013)
A targeted glycoproteomic approach identifies cadherin-5 as a novel biomarker of metastatic breast cancer
Simon A. Fry et al.
CANCER LETTERS (2013)
VE-Cadherin and Endothelial Adherens Junctions: Active Guardians of Vascular Integrity
Monica Giannotta et al.
DEVELOPMENTAL CELL (2013)
The DietCompLyf study: A prospective cohort study of breast cancer survival and phytoestrogen consumption
Ruth Swann et al.
MATURITAS (2013)
Usefulness of Traditional Serum Biomarkers for Management of Breast Cancer Patients
Peppino Mirabelli et al.
BIOMED RESEARCH INTERNATIONAL (2013)
The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer
Zahra M. A. Mohammed et al.
BMC CLINICAL PATHOLOGY (2013)
Evaluation of sequential FDG-PET/CT for monitoring bone metastasis of breast cancer during therapy: correlation between morphological and metabolic changes with tumor markers
Takashi Katayama et al.
ANNALS OF NUCLEAR MEDICINE (2012)
Breast Cancer Recurrence Diagnosis Suspected on Tumor Marker Rising Value of Whole-Body 18FDG-PET/CT Imaging and Impact on Patient Management
Laurence Champion et al.
CANCER (2011)
New Developments in Hormone Receptor-Positive Disease
Martine J. Piccart-Gebhart
ONCOLOGIST (2011)
Angiogenesis Markers Quantification in Breast Cancer and Their Correlation with Clinicopathological Prognostic Variables
Jan Rykala et al.
PATHOLOGY & ONCOLOGY RESEARCH (2011)
Proteome-wide post-translational modification statistics: frequency analysis and curation of the swiss-prot database
George A. Khoury et al.
SCIENTIFIC REPORTS (2011)
EMT, the cytoskeleton, and cancer cell invasion
Mahmut Yilmaz et al.
CANCER AND METASTASIS REVIEWS (2009)
The basics of epithelial-mesenchymal transition
Raghu Kalluri et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Serum tumour markers: how to order and interpret them
C. M. Sturgeon et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Vascular endothelial cadherin promotes breast cancer progression via transforming growth factor β signaling
Myriam Labelle et al.
CANCER RESEARCH (2008)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
VE-cadherin is a critical endothelial regulator of TGF-β signalling
Noemi Rudini et al.
EMBO JOURNAL (2008)
Serum tumor markers in breast cancer: Are they of clinical value?
MJ Duffy
CLINICAL CHEMISTRY (2006)
Breast cancer metastasis: Markers and models
B Weigelt et al.
NATURE REVIEWS CANCER (2005)
Alterations in vascular gene expression in invasive breast carcinoma
BS Parker et al.
CANCER RESEARCH (2004)
Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database
WF Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Tumour marker measurements in the diagnosis and monitoring of breast cancer
KL Cheung et al.
CANCER TREATMENT REVIEWS (2000)
Share Paper
